Bal Pharma consolidated net profit rises 9.47% in the September 2024 quarter

Sales decline 20.37% to Rs 73.69 crore

Net profit of Bal Pharma rose 9.47% to Rs 1.04 crore in the quarter ended September 2024 as against Rs 0.95 crore during the previous quarter ended September 2023. Sales declined 20.37% to Rs 73.69 crore in the quarter ended September 2024 as against Rs 92.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales73.6992.54 -20 OPM %10.448.32 -PBDT3.844.02 -4 PBT1.361.60 -15 NP1.040.95 9

Powered by Capital Market - Live News